The short version of visceral adiposity fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-31 and is reviewed periodically as new material appears.
Identity and purity are judged through a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact peptide from truncated, oxidized, and deamidated variants, and the resulting peak-area percentages yield a purity figure. Electrospray ionization mass spectrometry confirms the expected molecular mass and can expose unanticipated modifications. Amino acid analysis and peptide mapping support sequence fidelity, while water content, pH, sterility, and bacterial endotoxin testing describe the physical and microbiological attributes of a finished lot.
Regulatory position depends on jurisdiction and on the form in which the material is sold. A branded product holds approval in the United States for a defined indication, and prescribing is confined to that label. Material marketed for laboratory research is not evaluated for human use and carries no such clearance. Independent verification therefore rests on certificates of analysis, third-party testing, and documented chain of custody. The substance also appears on the World Anti-Doping Agency prohibited list within the category covering growth hormone-releasing factors.
Lyophilized material is typically held under refrigeration between two and eight degrees Celsius, shielded from light and ambient moisture. Peptides of this size adsorb to glass and plastic, so working procedures often call for low-binding containers and as few transfers as possible. Absorbed water during weighing shifts the apparent mass of a sample, and controlling room humidity reduces that source of error. Once dissolved, solutions are kept cold and used within the interval printed on the accompanying label or certificate. Degradation accelerates markedly in dilute aqueous form.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized cake or loose powder |
| Solubility | Freely soluble in water | Salt form dissolves readily in aqueous buffer |
| Storage (lyophilized) | 2 to 8 °C | Protect from light and moisture |
| Common purity method | Reversed-phase HPLC | Reported as peak-area percentage |
| Identity confirmation | Electrospray mass spectrometry | Measured mass compared with theoretical value |
Common analytical approaches include reversed-phase high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Peptide mapping after enzymatic digestion can verify the expected sequence. Immunoassays may be used to measure the compound or its downstream markers, but they can cross-react with related peptides and require careful validation. Impurity profiles typically include truncated sequences, oxidized methionine residues, and residual solvents from synthesis. Each method reports a different property, so no single assay establishes overall quality.
Storage claims vary across suppliers, and published stability data for specific formulations are limited. Extrapolating from related peptides is common but not a substitute for direct measurement. For research use, documentation such as a certificate of analysis is often requested to confirm identity and purity. What constitutes an acceptable purity threshold depends on the intended application. Open questions remain about how temperature excursions during shipping affect long-term peptide integrity. Independent verification by an end user is not routinely reported.
Lyophilized tesamorelin is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light and moisture. Peptides in this class are often kept frozen at minus 20 degrees Celsius for longer periods. Reconstituted solutions are typically used within a defined window because hydrolysis and oxidation proceed faster in liquid form. Container material and headspace also influence how long a preparation retains its expected profile. Specific stability figures depend on concentration and buffer composition.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
Once reconstituted, the peptide is handled as a solution and is less stable than the lyophilized powder. Aqueous solutions are commonly kept cold and used within a defined period. Buffer composition and pH influence degradation rates, with extremes of acidity or alkalinity accelerating hydrolysis. Preservatives may be added in multi-dose formats to limit microbial growth. Freezing and thawing of solutions is generally avoided because it can cause precipitation or loss of activity.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass and detects chemical modifications. Peptide mapping and amino acid analysis can verify sequence integrity. Water content is measured by Karl Fischer titration, and residual solvents may be checked by gas chromatography. These methods together support batch-to-batch consistency and routine quality control.
=== Historical legality and modern-day usage in the United States === On October 24, 1968, possession of LSD was made illegal in the United States. The last FDA approved study of LSD in patients ended in 1980, while a study in healthy volunteers was made in the late 1980s. Legally approved and regulated psychiatric use of LSD continued in Switzerland until 1993. As of 2017, about 10% of people in the United States have used LSD at some point in their lives, while 0.7% have used it in the last year. The use of LSD among US adults increased by 56.4% from 2015 to 2018. In November 2020, Oregon became the first US state to decriminalize possession of small amounts of LSD after voters approved Ballot Measure 110.
== Analysis of polymers using end groups == Because of the importance of end groups, there have been many analytical techniques developed for the identification of the groups. The three main methods for analyzing the identity of the end group are by NMR, mass spectrometry (MS) or vibrational spectroscopy (IR or Raman). Each technique has its advantages and disadvantages, which are details below.
== Chemistry == Carvedilol is a highly lipophilic compound with an experimental log P of 3.8 to 4.19 and a predicted log P of 3.05 to 4.2. It showed the third highest predicted lipophilicity of 30 clinically relevant beta blockers, with the second and third most lipophilic beta blockers predicted to be bopindolol and penbutolol, respectively.
Sources: en.wikipedia.org
In March 2007, in the final verdict by the Supreme Court of Cassation, stated that "in the years of 1994 to 1998 there was no ascertained positive case of doping substances by Juventus players, that the purchase of erythropoietin or its administration to the athletes of the club does not emerge from any act of the trial, and that the same expert had identified the possibility of an administration of erythropoietin in distant terms from the sure evidence ("very probable" and in two cases "practically certain"): it is that therefore, the judgement of probability and not of certainty, did not allow for a statement of responsibility." The verdict also went on to say: "In response to the conclusion taken, the territorial court notes that there were no deferred values higher than the limits set in the various antidoping protocols and that the situation of the Juventus players, both with reference to the average hematological values, and in relation to that of material balance, did not differ from the national average population.
While working in John O’Brien's lab in the Department of Neurosciences, School of Medicine, UCSD, with funding support from NIH, Patton began extensive work analyzing the nature of human milk, with special emphasis on its mucins. He discovered that the mucins MUC1 and MUC-X, which are transferred to the milk fat globule upon secretion, have greater size in human milk and therefore may carry greater protection against infections and injurious environmental agents. In the 55 years of his active research career Patton collaborated with more than 100 scientists from around the world, including with his twin sons, John and Richard, who both went on to successful careers in the sciences, each of them writing dissertations under colleagues of their father. And, coming full circle, in some of his final research he collaborated with R. V. Josephson, son of his first mentor at Penn State in the 1940s. A scholarship is named in honor of D. V. Josephson and Patton at Penn State, awarded to graduate students and faculty on a yearly rotating basis. In addition to the textbook Patton co-wrote with R. Jenness (1959), Principles of Dairy Chemistry, New York and London), he addressed a broader audience in a Scientific American article “Milk” (1969, 221: 59–68) and in his final publication: Milk: Its Remarkable Contribution to Human Health and Well-being (2004, New York), a comprehensive treatment of its subject and advocacy for its benefits.
On April 17, 1848, a 42-year-old woman named Lu-shi was treated for hypertrophy in a Chinese hospital. She was treated by a missionary physician. On December 24, 1849, the left breast, measuring 67 cm (26 in) in circumference, and weighing 2.7 kg (6.0 lb), was removed in a procedure lasting three and a half minutes. The right breast was removed one month later. It measured 61 cm (24 in) in circumference and weighed 2.5 kg (5.5 lb). In 2005, a woman reported that her breasts grew at puberty from nothing to a C cup in one month. When she became pregnant for the first time, her breasts increased two cup sizes in a few days. Immediately after her first birth, her breasts grew three cup sizes. After her second child was born, her breasts increased six cup sizes. After her third childbirth, they grew ten cup sizes, and after her fourth child was born, they grew nine cup sizes. In this instance, the swelling abated about 10 days after childbirth, but her bra cup size remained E to a G for the next year. About one year postpartum, her breasts rapidly atrophied to AA cup size. One of the most severe cases of macromastia was reported from Ilorin in Nigeria. In 2007, Ganiyu Adebisi Rahman and his colleagues reported the case of a 26-year-old woman who presented with massive swelling of her breasts and bilateral axillary swellings of 6 years duration. Rahman led a team of surgeons in Ilorin to perform a total bilateral excision of the hypertrophied axillary breasts, and bilateral breast amputation with composite nipple-areola complex graft of the normally located breasts.
== Treatment == There is no distinct treatment option that can undo the effects and damage from rhabdomyolysis because it is a type of necrosis, where the tissue and body cells die prematurely. However, the rate of the pathology that can lead to more complications can be decreased by acting early and consistently. Overall treatment depends on preventing kidney failure (renal failure) which is done by rehydrating the patient. It also depends on making urine have a more basic pH (alkalinization of urine).
Sources: en.wikipedia.org
A base and an acid, e.g., NaOH + HCl → NaCl + H2O A metal and an acid, e.g., Mg + H2SO4 → MgSO4 + H2 A metal and a non-metal, e.g., Ca + Cl2 → CaCl2 A base and an acid anhydride, e.g., 2 NaOH + Cl2O → 2 NaClO + H2O An acid and a base anhydride, e.g., 2 HNO3 + Na2O → 2 NaNO3 + H2O An acid anhydride and a base anhydride, e.g., CO2 + Na2O → Na2CO3 In the salt metathesis reaction where two different salts are mixed in water, their ions recombine, and the new salt is insoluble and precipitates. For example: Pb(NO3)2 + Na2SO4 → PbSO4↓ + 2 NaNO3
Micelles consist of a hydrophobic inner core surrounded by a hydrophilic outer shell that is exposed to a solvent, and their structures can be spheres, disks or wormlike assemblies. Micelles form spontaneously when the concentration is above a critical micelle concentration and temperature. Amphiphiles with an intermediate level of hydrophobicity prefer to assemble into bilayer vesicles. Vesicles are spherical, hollow, lamellar structures that surround an aqueous core. The hydrophobic moiety faces inwards and forms the inner section of the bilayer, and the hydrophilic moiety is exposed to the aqueous environment on the inner and outer surface. Micelle structures have a hydrophobic interior and hydrophilic exterior. There is normally a distinct relationship between the amphiphilic character of a peptide and its function in that the amphiphilic character determines the self-assembly properties, and in turn this is what gives the peptide its functionality. The level of amphiphilicity can vary significantly in peptides and proteins; as such they can display regions that are either hydrophobic or hydrophilic in nature. An example of this is the cylindrical structure of an α-helix, as it could contain a section of hydrophobic residues along one face of the cylinder and a hydrophilic section of residues on the opposite face of the cylinder. For β-sheet structures, the peptide chain can be composed of alternating hydrophilic and hydrophobic residues, so that the side chains of the residues are displayed on opposite faces of the sheet.
The Portuguese agriculture sector accounted for 2.9% of the country's total GDP as of 2024. Portugal's agricultural land encompassed an area of approximately 3,697,000 ha (36,970 km2) as of 2023, of which 17.4% was dedicated to organic farming, representing the fifth-highest share worldwide. Despite the extent of the country's agricultural land, the diversity of Portugal's edaphoclimatic and agroecological conditions enables the cultivation of various agricultural products such as wheat, maize, and rice, with each one having an important role in the primary sector, and resulting in an agricultural self-sufficiency rate of 85% as of 2018. Portugal ranks sixth in the world in seafood consumption per capita, with each Portuguese person consuming on average 54 kg (119 lb) of fish in 2023. The high fish consumption in Portugal is due to tradition and cultural roots, politics, dynamics of the fish market system, and geography. Strong demand for seafood makes the fisheries a valuable national asset. While Portugal captured 185,000 tonnes (182,000 long tons; 204,000 short tons) of fish in 2019, down from the 222,000 t (218,000 long tons; 245,000 short tons) in 2010, fish and seafood represent the single highest import of biocapacity from abroad, amounting to 1,600,000 global hectares in total.
== Early life and education == Crick was the first son of Harry Crick and Annie Elizabeth Crick (née Wilkins). He was born on 8 June 1916 and raised in Weston Favell, then a small village near the English town of Northampton, in which Crick's father and uncle ran the family's boot and shoe factory. His grandfather, Walter Drawbridge Crick, an amateur naturalist, wrote a survey of local foraminifera (single-celled protists with shells), corresponded with Charles Darwin, and had two gastropods (snails or slugs) named after him. At an early age, Francis was attracted to science and what he could learn about it from books. As a child, he was taken to church by his parents. But by about age 12, he said he did not want to go any more as he preferred a scientific search for answers over religious belief. Walter Crick, his uncle, lived in a small house on the south side of Abington Avenue; he had a shed at the bottom of his little garden where he taught Crick to blow glass, do chemical experiments and to make photographic prints. When he was eight or nine he transferred to the most junior form of the Northampton Grammar School, on the Billing Road. This was about 1.25 mi (2 km) from his home so he could walk there and back, by Park Avenue South and Abington Park Crescent, but he more often went by bus or, later, by bicycle. The teaching in the higher forms was satisfactory, but not as stimulating. After the age of 14, he was educated at Mill Hill School in London (on a scholarship), where he studied mathematics, physics, and chemistry with his best friend John Shilston.
== Awards == 1977, Young Investigator award, National Institutes of Health (NIH) 1979, Research Career Development Award, NIH 1983, Recognition Award for Young Scholars, American Association of University Women 1987, John J. Abel Award in Pharmacology, American Society for Pharmacology and Experimental Therapeutics (ASPET) Limbird was the second woman to receive this award, the first being Eva King Killam in 1954. 1989, MERIT Award, NIH 1994, Distinguished Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD, now Brain & Behavior Research Foundation). 1998, Distinguished Alumni Award, College of Wooster 2004, Goodman and Gilman Award in Drug Receptor Pharmacology, ASPET 2013, Julius Axelrod Award, ASPET.
Sources: en.wikipedia.org
Reconstituted solutions are kept cold and used within the period stated on the label or certificate. Repeated warming and cooling cycles should be avoided because they encourage aggregation and gradual loss of potency.
Mass spectrometry serves as the primary identity check, since the measured mass must agree with the theoretical value for a 44-residue sequence. Chromatographic retention time and peptide mapping supply supporting evidence.
Certificates of analysis and independent testing tie a specific lot to specific measured results. Without that link, purity and identity claims rest on the supplier's own statement rather than on verifiable data.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.